Azurrx Biopharma Inc (AZRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AZRX | AZN | AMGN | GILD | BMY |
| Company | Azurrx Biopharma Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 3.38 | 198.71 | 340.99 | 139.00 | 59.12 |
| High | 3.66 | 200.00 | 341.32 | 139.31 | 59.23 |
| Low | 3.38 | 196.95 | 335.06 | 137.15 | 57.88 |
| Latest | 3.45 | 199.93 | 337.71 | 138.28 | 58.03 |
| Change | +0.07 | -2.90 | -4.86 | -1.85 | -1.30 |
| % Change | +2.07% | -1.43% | -1.42% | -1.32% | -2.19% |
| Volume | 629,000 | 1,171,926 | 709,954 | 1,378,583 | 2,320,961 |
| 20-Day Average Volume | 1,053,631 | 1,804,432 | 2,551,725 | 5,898,761 | 13,155,381 |
| Previous Close | 3.38 | 202.83 | 342.57 | 140.13 | 59.33 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.38 | 192.03 | 354.99 | 140.62 | 59.14 |
| 20-Day Raw Stochastic | 2.44% | 72.47% | 4.28% | 25.24% | 26.79% |
| 20-Day Relative Strength | 30.93 | 54.54 | 37.78 | 45.18 | 46.63 |
| Weighted Alpha | -75.37 | +47.44 | +16.87 | +31.59 | +19.87 |
| Today's Opinion | 100% Sell | 88% Buy | 24% Buy | 40% Buy | 48% Buy |
| Previous Opinion | 100% Sell | 88% Buy | 24% Buy | 40% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 80% Buy | 88% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -22.12% since 09/14/21 | +2.43% since 03/30/26 | -3.30% since 03/30/26 | +1.07% since 03/30/26 | -2.90% since 03/30/26 |
| Low | 3.36 on 09/20/21 | 193.55 on 03/31/26 | 335.59 on 04/07/26 | 137.17 on 04/07/26 | 57.88 on 04/07/26 |
| High | 4.39 on 09/15/21 | 204.75 on 04/06/26 | 357.00 on 04/01/26 | 141.49 on 04/01/26 | 62.22 on 04/01/26 |
| 1-Month | |||||
| %Chg | -40.60% since 08/20/21 | +2.25% since 03/06/26 | -8.67% since 03/06/26 | -4.26% since 03/06/26 | -3.80% since 03/06/26 |
| Low | 3.36 on 09/20/21 | 182.39 on 03/24/26 | 335.59 on 04/07/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 7.05 on 09/10/21 | 204.75 on 04/06/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | -57.06% since 06/21/21 | +4.35% since 01/07/26 | -1.21% since 01/07/26 | +10.82% since 01/07/26 | +2.25% since 01/07/26 |
| Low | 3.36 on 09/20/21 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.33 on 01/09/26 | 53.54 on 01/21/26 |
| High | 8.57 on 08/18/21 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -75.18% since 03/19/21 | +15.64% since 10/07/25 | +14.20% since 10/07/25 | +18.00% since 10/07/25 | +29.86% since 10/07/25 |
| Low | 3.36 on 09/20/21 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 14.90 on 03/22/21 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 32,175 | 314,570,656 | 184,668,512 | 173,932,464 | 121,136,144 |
| Shares Outstanding, K | 9,326 | 1,550,908 | 539,068 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -32,670,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -9,280,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.51 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 11/15/21 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.22 | 15.92 | 17.14 | 9.69 |